CA19-9 or CEA Decline after the First Cycle of Treatment Predicts Survival in Advanced Biliary Tract Cancer Patients Treated with S-1 and Cisplatin Chemotherapy

PURPOSE: While tumor markers (carbohydrate antigen 19-9 [CA 19-9] and carcinoembryonic antigen [CEA]) can aid in the diagnosis of biliary tract cancer, their prognostic role has not been clearly elucidated. Therefore, this study was conducted to evaluate the prognostic role of tumor markers and tumo...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Res Treat
Main Authors: Lee, Dae-Won, Im, Seock-Ah, Kim, Yu Jung, Yang, Yaewon, Rhee, Jiyoung, Na, Im Il, Lee, Kyung-Hun, Kim, Tae-Yong, Han, Sae-Won, Choi, In Sil, Oh, Do-Youn, Kim, Jee Hyun, Kim, Tae-You, Bang, Yung-Jue
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Cancer Association 2017
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5512384/
https://ncbi.nlm.nih.gov/pubmed/28111425
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2016.326
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados